The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis

COVID-19 associated brain/spinal cord lesions and leptomeningeal enhancement: A meta-analysis of the relationship to CSF SARS-CoV-2

Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions

Cerebrospinal fluid from COVID-19 patients with olfactory/gustatory dysfunction: A review

Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the Virus on Neurocognitive Trajectories

Systematic Review of Cases of Acute Myelitis in Individuals with COVID-19

COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival

Persistent visual dysfunction following PRES due to COVID-19: Case series and literature review

Risk and outcomes of COVID-19 in patients with multiple sclerosis

Predictive factors of smell recovery in a clinical series of 288 COVID-19 patients with olfactory dysfunction

Guillain-Barré syndrome following ChAdOx1-S/nCoV-19 vaccine

Guillain-Barré syndrome variant occurring after SARS-CoV-2 vaccination

Skeletal Muscle and Peripheral Nerve Histopathology in COVID-19

Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans